Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease | Zendy

Marie FrimodtMøller | Zendy; A. H. Nielsen | Zendy; Svend Strandgaard | Zendy; AnneLise Kamper | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease

Author(s) -

Marie FrimodtMøller,

A. H. Nielsen,

Svend Strandgaard,

AnneLise Kamper

Publication year - 2009

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfp547

Subject(s) - medicine , candesartan , enalapril , hyperkalemia , kidney disease , renal function , blood pressure , blockade , creatinine , urology , cardiology , angiotensin ii , angiotensin converting enzyme , receptor

Dual blockade of the renin-angiotensin system (RAS) has been claimed to have a specific renal protective effect in chronic kidney disease (CKD). The present short-term study reports on the feasibility of dual blockade in a consecutive group of patients with CKD stage 3-5.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research